Abstract:Background Drug-drug interactions (DDIs) always cause unexpected and even adverse drug reactions. It is important to identify DDIs before drugs are used in the market. However, preclinical identification of DDIs requires much money and time. Computational approaches have exhibited their abilities to predict potential DDIs on a large scale by utilizing pre-market drug properties (e.g. chemical structure). Nevertheless, none of them can predict two comprehensive types of DDIs, including enhancive and degressive DDIs, which increases and decreases the behaviors of the interacting drugs respectively. There is a lack of systematic analysis on the structural relationship among known DDIs. Revealing such a relationship is very important, because it is able to help understand how DDIs occur. Both the prediction of comprehensive DDIs and the discovery of structural relationship among them play an important guidance when making a co-prescription. Results In this work, treating a set of comprehensive DDIs as a signed network, we design a novel model (DDINMF) for the prediction of enhancive and degressive DDIs based on semi-nonnegative matrix factorization. Inspiringly, DDINMF achieves the conventional DDI prediction (AUROC = 0.872 and AUPR = 0.605) and the comprehensive DDI prediction (AUROC = 0.796 and AUPR = 0.579). Compared with two state-of-the-art approaches, DDINMF shows it superiority. Finally, representing DDIs as a binary network and a signed network respectively, an analysis based on NMF reveals crucial knowledge hidden among DDIs. Conclusions Our approach is able to predict not only conventional binary DDIs but also comprehensive DDIs. More importantly, it reveals several key points about the DDI network: (1) both binary and signed networks show fairly clear clusters, in which both drug degree and the difference between positive degree and negative degree show significant distribution; (2) the drugs having large degrees tend to have a larger difference between positive degree and negative degree; (3) though the binary DDI network contains no information about enhancive and degressive DDIs at all, it implies some of their relationship in the comprehensive DDI matrix; (4) the occurrence of signs indicating enhancive and degressive DDIs is not random because the comprehensive DDI network is equipped with a structural balance.

MTDDI: a Graph Convolutional Network Framework for Predicting Multi-Type Drug-Drug Interactions

deepMDDI: A deep graph convolutional network framework for multi-label prediction of drug-drug interactions

Multitype drug interaction prediction based on the deep fusion of drug features and topological relationships

MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction

DPDDI: a deep predictor for drug-drug interactions

TP-DDI: A Two-Pathway Deep Neural Network for Drug–Drug Interaction Prediction

CNN-DDI: a learning-based method for predicting drug–drug interactions using convolution neural networks

A Multimodal Deep Learning Framework for Predicting Drug-Drug Interaction Events.

MGDDI: A multi-scale graph neural networks for drug-drug interaction prediction

MTrans: M-Transformer and Knowledge Graph-Based Network for Predicting Drug–Drug Interactions

MASMDDI: multi-layer adaptive soft-mask graph neural network for drug-drug interaction prediction

STNN-DDI: A Substructure-aware Tensor Neural Network to Predict Drug-Drug Interactions

Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization

Prediction of multiple types of drug interactions based on multi-scale fusion and dual-view fusion

MATT-DDI: Predicting Multi-Type Drug-Drug Interactions Via Heterogeneous Attention Mechanisms.

Interpretable multi-view attention network for drug-drug interaction prediction.

An effective framework for predicting drug–drug interactions based on molecular substructures and knowledge graph neural network

Structural Network Embedding Using Multi-modal Deep Auto-encoders for Predicting Drug-drug Interactions

Deep learning for drug‐drug interaction prediction: A comprehensive review

DDI‐Transform: A neural network for predicting drug‐drug interaction events

MTNE: A Multitext Aware Network Embedding for Predicting Drug-Drug Interaction.